Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Antonios Valachis
affiliation not provided to SSRN
Contact
affiliation not provided to SSRN
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
15
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A nationwide population-based study on the incidence and prognosis of HER2-positive breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapy
Number of pages: 30
Posted: 20 Mar 2026
Antonios Valachis,
Xingrong Liu
,
Balazs Acs
,
Johan Hartman
,
Theodoros Foukakis
and
Alexios Matikas
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Karolinska Institutet - Department of Oncology-Pathology,
affiliation not provided to SSRN
and Karolinska University Hospital - Department of Oncology/Pathology
Downloads
15
(1,518,554)
View PDF
Download
Abstract:
Adjuvant, APHINITY, breast cancer, pertuzumab, prognosis
Feedback
